Article
Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
Molecular microbiology - 1 Apr 2000
Douthwaite S, Hansen L H, Mauvais P
Abstract excerpt
The macrolide antibiotic erythromycin and its 6-O-methyl derivative (clarithromycin) bind to bacterial ribosomes primarily through interactions with nucleotides in domains II and V of 23S rRNA. The domain II interaction occurs between nucleotide A752 and the macrolide 3-cladinose moiety. Removal of the cladinose, and substitution of a 3-keto group (forming the ketolide RU 56006), results in loss of the A752...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
